Critical analysis of overdiagnosis in breast cancer screening. Risk-adapted screening protocols may optimize benefit-harm ratio. - Scholz Oliver Dr.med. in Nürnberg ⇒ in Das Örtliche , The authors make a compelling case for personalized medicine. Genetic profiling should become standard in...